Classifications

• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
  • C08F2/00—Processes of polymerisation
  • C08F2/38—Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
  • C08F2/40—Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation using retarding agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C7/00—Purification; Separation; Use of additives
  • C07C7/20—Use of additives, e.g. for stabilisation
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
  • C08F12/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
  • C08F12/02—Monomers containing only one unsaturated aliphatic radical
  • C08F12/04—Monomers containing only one unsaturated aliphatic radical containing one ring
  • C08F12/06—Hydrocarbons
  • C08F12/08—Styrene
• • C—CHEMISTRY; METALLURGY
  • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
  • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
  • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
  • C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
  • C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
  • C09K15/08—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen containing a phenol or quinone moiety

Definitions

• This invention relates to compositions of matter and methods of using them to inhibit the polymerization of vinyl aromatic monomers.
• Many of these monomers undesirably polymerize at various stages of their manufacture, processing, handling, storage, and use. These undesirable polymerization reactions result in a loss in production efficiency because they consume valuable reagents and because they require and additional purification steps to remove the undesired polymers. Undesired polymerization reactions are particularly problematic by vinyl aromatic monomers and form unwanted polymer during the purification process.
• Inhibitors prevent polymerization reactions from occurring. Inhibitors however are consumed rapidly. In cases of emergency when for a mechanical or other reason more inhibitor cannot be added, previously added inhibitor will be rapidly consumed and the unwanted polymerization reactions will then rapidly recur. Retarders slow down the rate of polymerization reactions but are not as effective or as inhibitors. Retarders however are usually not consumed as quickly so they are more reliable in cases of emergency. At first only retarders such as sulfur, and dinitrophenols (DNP) (including 2,6- dinitrophenol, 2,4-dinitrocresol, and 2-sec-butyl-4,6-dinitrophenol (DNBP)) were used to prevent unwanted polymerization reactions.
• DNP dinitrophenols
• DNBP 2-sec-butyl-4,6-dinitrophenol
• DNP retarders however are highly toxic and there is a significant need for a replacement for them.
• One class of compounds that was hoped can be a retarder in the place of DNP are quinone methides.
• Quinone methides slow the rate of polymer formation under static conditions and do not need to be frequently re-fed.
• quinone methides must be used in fairly high dosages, so they are not very economical to use by themselves. Examples of quinone methide compounds are in US Patent Number 4,003,800. These compound however are not stable enough for sustained use in industrial settings. Other applications of quinone methides are found in US Patent Numbers 5,583,247, and 7,045,647. Previous examples of inhibitor-retarder combinations that do not use DNP are US
• At least one embodiment of the invention is directed towards a method for inhibiting the premature polymerization of vinyl aromatic monomers by adding to the monomers an effective amount of a composition comprising at least one inhibitor and at least one retarder.
• the retarder is a substituted quinone methide.
• At least one embodiment of the invention is directed towards a method in which the retarder is selected from the list consisting of: 2,6-di-t-butyl-7-cyano quinone methide, 2,6-di- t-buryl-7-carboxy quinone methide, 2,6-di-t-butyl-7-methoxycarbonyl quinone methide, and any combination thereof.
• the inhibitor can be an alkylhydroxylamine.
• the retarder can be non-toxic.
• the inhibitor can have a dosage of between 1 to 200 ppm, based on the weight of the monomer.
• the retarder can have a dosage of between 1 to 1200 ppm, based on the weight of the monomer.
• At least one embodiment of the invention is directed towards a method in which the inhibitor and retarder are added separately to the monomer.
• the amount of inhibitor in the presence of the monomers can be maintained at a relatively constant amount by adding the inhibitor in increments over time.
• the inhibitor can be added intermittently or continuously and can be continuously dispersed throughout the monomer.
• the inhibitor can be selected from the list consisting of an alkylhydroxylamitie such as hydroxypropylhydroxylamine, diethylhydroxylamine, and any combination thereof.
• Detailed Description of the Invention hi at least one embodiment the premature polymerization of styrene in prevented by the addition of an inhibitor-retarder combination.
• induction time is the period of time in which in an ideal closed system a composition of matter completely prevents the formation of a particular polymer during a given reaction.
• inhibitor is a composition of matter that inhibits the formation of the particular polymer during an induction time but after the induction time has lapsed, the particular polymer's formation occurs at substantially the same rate that it would formed at in the absence of the composition of matter.
• the definition of "retarder” is a composition of matter, which does not have an induction time, but instead once added to the given reaction the composition of matter reduces the rate at which the formation of the particular polymer occurs relative to the rate at which it would have formed in the absence of the composition of matter.
• the inventive inhibitor is an alkylhydroxylamine selected from the list consisting of hydroxypropylhydroxylamine and diethylhydroxylamine and the inventive retarder is a 7-substituted-quinone methide.
• the 7-substituted-quinone methides is selected from the list consisting of a 2,6-di-t-butyl-7-cyano quinone methide, a 2,6-di-t-butyl-7 ⁇ carboxy quinone methide, and a 2,6 ⁇ di-t-butyl-7-methoxycarbonyl quinone methide.
• the effective amount of the combination of alkylhydroxylamine compound is typically about 1 to 200 ppm, based on the weight of the monomer.
• the effective amount of the combination of 7-cyano-quinone methide is typically about 1 to 400 ppm, based on the weight of the monomer. Amounts outside this range may be appropriate depending upon the conditions of use. For higher temperatures, the effective dosages will be higher.
• the inhibitor-retarder combination of the present invention is suitable for use over a wide range of temperatures, but temperatures employed with the monomers that are stabilized by the invention typically range from about 60 degrees Celsius to about 180 degrees Celsius.
• the inhibitor-retarder combination can be introduced into the monomer to be protected by any conventional method. It can be added as a concentrated solution in suitable solvents just upstream from the point of desired application by any suitable manner.
• the individual inhibitor and retarder components can be injected separately or in combination to a monomer-containing tank.
• the individual inhibiting components can also be injected separately along with the incoming feed or through separate entry points, provided there is an efficient distribution of the inhibitor-retarder combination.
• inhibitors are gradually depleted, it is generally advantageous to maintain the appropriate amount of the inhibitor mixture in the tank in increments over time. Adding inhibitors can be done either on a generally continuous basis or intermittently, in order to maintain the concentration of inhibitor mixture above the minimum required level.
• the retarders were added to each sample at a dosage of 350 ppm relative to monomer weight and the inhibitor was added at a dosage of 150 ppm relative to monomer weight in a continuous stirred tank reactor.
• the two samples were heated to 120 degrees Celsius and underwent a 1-hour residence.
• the prior art sample resulted in 539 ppm of unwanted polymer while the inventive retarder-inhibitor combination only had 38.5 ppm of unwanted polymer.
• Example 2 In a second example a comparison was made between a sample a prior art retarder-inhibitor combination comprising HPHA inhibitor and DNBP retarder and a sample of the inventive retarder-inhibitor combination comprising a 7-substituted-quinone methide retarder and an HPHA inhibitor.
• the retarders were added to each sample at a dosage of 350 ppm relative to monomer weight and the inhibitor was added at a dosage of 22.5 ppm relative to monomer weight in a continuous stirred tank reactor.
• the two samples were heated to 120 degrees Celsius and underwent a 1-hour residence.
• the prior art sample resulted in 573 ppm of unwanted polymer while the inventive retarder-inhibitor combination only had 62 ppm of unwanted polymer. This demonstrates that the inventive retarder-inhibitor combination is even capable of drastically preventing the production of unwanted polymer under emergency conditions where additional inhibitor cannot be added.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Medicinal Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Polymers & Plastics (AREA)
• Analytical Chemistry (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Water Supply & Treatment (AREA)
• Materials Engineering (AREA)
• Polymerisation Methods In General (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Compositions Of Macromolecular Compounds (AREA)

Priority Applications (7)

Applications Claiming Priority (2)

Publications (1)

Family

ID=41559765

Family Applications (1)

Country Status (11)

Cited By (5)

Families Citing this family (11)

Citations (7)

Family Cites Families (5)

• 2009
  • 2009-02-05 US US12/366,154 patent/US7651635B1/en active Active
• 2010
  • 2010-01-25 TW TW099101907A patent/TWI461406B/zh active
  • 2010-02-03 EP EP10704042A patent/EP2393765B1/en active Active
  • 2010-02-03 BR BRPI1005420-0A patent/BRPI1005420B1/pt active IP Right Grant
  • 2010-02-03 JP JP2011549218A patent/JP5536106B2/ja active Active
  • 2010-02-03 WO PCT/US2010/022977 patent/WO2010091040A1/en not_active Ceased
  • 2010-02-03 KR KR1020117018201A patent/KR101613760B1/ko active Active
  • 2010-02-03 ES ES10704042T patent/ES2398053T3/es active Active
  • 2010-02-03 CA CA2750187A patent/CA2750187C/en active Active
  • 2010-02-03 CN CN201080006847.0A patent/CN102307830B/zh active Active
  • 2010-02-03 SG SG2011056546A patent/SG173564A1/en unknown

Patent Citations (9)

Also Published As

Similar Documents

Legal Events